Introduction
Coronary artery calcium (CAC) is an imaging marker that is nearly pathognomonic for the presence of coronary atherosclerosis 1,2 and can be detected using noncontrast cardiac CT. Indeed, CAC testing is specific for the presence of coronary atherosclerosis and highly sensitive for increasing burden of obstructive atherosclerotic coronary artery disease. 3 CAC is also highly effective for risk stratification of selected asymptomatic patients. For example, elevated CAC >300 is associated with a nearly 10-fold increased risk of adverse coronary events after multivariate adjustment. 4 Equally important, the absence of CAC in asymptomatic adults is associated with a low mortality rate of 1% over 10 years. 5e7 Even mildly elevated CAC denotes risk, as patients with CAC scores between 1 and 10 have a 2-to 3-fold increased risk of cardiovascular adverse events and death compared with those with CAC ¼ 0. 6, 8, 9 Given these prognostic differences, a clinical finding of zero vs nonzero CAC has important implications for clinical decision making, including the decision to treat risk conditions with lifestyle vs pharmacotherapy. 10 Thus, there is a great deal of interest in studying the transition from zero to nonzero CAC. However, little is known about the characteristics of newly detected CAC, including its typical coronary distribution and burden.
To fill this gap, we used longitudinal CAC data from the Multi-Ethnic Study of Atherosclerosis (MESA) to describe the imaging characteristics related to the transition from zero to nonzero CAC. In particular, we asked the following questions: (1) At the first detection of new CAC, does CAC occur more commonly in 1 vessel vs multiple vessels? (2) 
Patient population
The study population for this analysis consisted of 3112 participants who had CAC ¼ 0 at baseline and had at least 1 additional CT scan (scored on a per-vessel basis) during MESA follow-up. After the initial baseline scan, participants underwent repeat CT scans during different follow-up visits as per the prespecified MESA protocol. MESA visits 2, 3, 4, and 5 included subjects who had follow-up CT scans at mean 1.7 AE 0.3, 3.2 AE 0.4, 4.9 AE 0.5, and 9.7 AE 0.6 years, respectively, after the initial baseline scan. In MESA, not all participants had follow-up scan at each of the visits. As part of the study design, approximately half (n ¼ 1522) of the participants received repeat scan at visit 2 and the other half (n ¼ 1425) at visit 3. Visit 4 prioritized participants without scan at visit 3 and included 677 participants with CAC ¼ 0 on prior visits. During visit 5, a total of 1461 participants with CAC ¼ 0 on prior visits received repeat scan and preferentially included participants with scan from visits 3 and 4 ( Supplementary Fig. 1 ). Repeat CT scanning in MESA was unrelated to specific individual participant characteristics. All participants with CAC ¼ 0 at baseline received at least 1 repeat scan (100%), whereas 47% had 2 total scans, 42% had 3 total scans, and 11% had 4 total scans over MESA follow-up.
2.3.
Cardiac CT protocol and CAC scoring Baseline cardiac CT was performed at 3 sites using a cardiacgated electron-beam CT scanner and at 3 sites using 4-slice multidetector CT. Each participant was scanned twice consecutively, and the images were interpreted at the MESA CT reading center at Harbor-UCLA Medical center, Los Angeles, CA. The results of the 2 scans were averaged to provide a more accurate point estimate of the amount of calcium present. Carr et al 12 have reported details of the methods used by MESA for CT scanning and interpretation. The amount of calcium was quantified with the Agatston scoring method. 13 When CAC was detected on CT images, its location was ascertained to left main (LM), left anterior descending (LAD), left circumflex (LCX), or right coronary arteries (RCA). Data regarding segmental distribution of CAC within individual coronary arteries were not available for our analysis. The kappa statistic for agreement on presence of any CAC was 0.92.
Risk factor assessment
As part of the baseline examination, study teams at each of the 6 centers collected information on cardiovascular risk factors. 
Statistical analysis
Baseline characteristics of the overall study population (N ¼ 3112) are presented in aggregate and by incident CAC status (follow-up CAC ¼ 0 vs follow-up CAC >0). Continuous variables are presented as mean AE standard deviation, whereas categorical variables are presented as total number and the proportion of the total. Differences between 2 groups were compared using the chi-square analysis for categorical variables and using 2-sample t tests for normally distributed continuous variables. Kruskal-Wallis equality of population rank tests were used to compare distributions between groups of non-normally distributed continuous variables. The remainder of the analyses focused on patients with newly detected CAC during follow-up (N ¼ 1125). To characterize the anatomic distribution of new-onset CAC over time in MESA, we described new-onset CAC as occurring in a single vessel (LM, RCA, LAD, LCX) or in multiple vessels (2, 3, or 4 vessels). We then calculated the adjusted marginal probabilities of each CAC distribution pattern using the "margins" command in STATA version 13 (Stata Corp, College Station, TX, USA). Probabilities were postestimated following a multivariate logistic regression model adjusted for the following variables: age, race, sex, time to CAC >0 detection, HTN status, household income (a measure of socioeconomic status), smoking status, diabetes status, LDL-C >160 mg/dL, use of lipid-lowering medications, and obesity (BMI >30 kg/ m 2 ). Time to CAC >0 detection was included in the models to account for the effect of the differential time between scans of individual participants in MESA. Marginal probabilities should not be considered the absolute prevalence of CAC by particular attribute (ie, race) but rather the residual differences in new-onset CAC that remain within that attribute after adjusting for other risk factors.
To characterize the burden of newly detected CAC over time in MESA, we assigned individuals to distinct CAC score categories (1e10, 11e100, and >100) as well as summarized the median Agatston score at the first detection of CAC. Using the chi-square analysis and Kruskal-Wallis testing, we assessed for differences in CAC burden by anatomic distribution (individual vessel involvement in those with single vessel CAC), as well as for differences in CAC burden between single-vessel and multivessel CAC. Statistical analysis was performed using Stata 13. A 2-sided P value of <.05 was used to indicate statistical significance. Table 1 summarizes the characteristics of our overall study sample. A total of 3112 subjects were included in the study. Average age was 57.9 AE 9 years and approximately 64% were female. The race distribution of our sample includes 34% White, 12% Chinese American, 31% Black, and 23% Hispanic.
Results

Baseline characteristics
Approximately 1125 subjects of our study sample (36%) developed new CAC with a mean time to detection of 6.1 AE 3.4 years. The percentage of subjects who developed new CAC at visit 2, 3, 4, and 5 were 11%, 21%, 22%, and 34%, respectively. The mean time to detection of new CAC was shorter in males (5.9 AE 3.4 years) compared to females (6.3 AE 3.4 years) and did not differ among subjects from different race groups.
New CAC was more prevalent among males, and the mean age of these subjects was higher when compared to subjects who did not develop CAC on follow-up scans. There was higher prevalence of HTN, DM, and smoking among subjects with new CAC compared to those with CAC ¼ 0. Subjects with new CAC demonstrated significantly higher systolic blood pressure, diastolic blood pressure, BMI, cholesterol, LDL-C, Framingham risk score, cardiovascular disease risk score and lower HDL-C compared to CAC ¼ 0 group. Baseline use of lipid-lowering and antihypertensive medications was significantly higher in subjects with new CAC. Participants with new CAC also had more number of follow-up CAC scans compared to CAC ¼ 0 group (Table 1 ).
Coronary distribution of new CAC
New CAC most commonly involved 1 vessel (unadjusted probability of 72%). Over the entire range of time from the baseline scan, 1 vessel involvement remained the most common presentation of new CAC (Fig. 1A ). Among subjects with 1 vessel involvement, the LAD was the most common vessel affected, and this pattern continued over the entire range of time from baseline scans. LAD involvement was followed in order of frequency by the RCA, LCX, and LM coronary arteries ( Table 2 ; Fig. 1B ). Multivessel involvement of new CAC was seen in 28% of subjects. With increased time from baseline scan, there was increased frequency of multivessel involvement of new CAC (15% at visit 2 vs 35% at visit 5). However, 1 vessel involvement of new CAC was the most common pattern even at visit 5, which occurred nearly 10 years after baseline scan ( Table 2 ; Fig. 1A ).
Association between risk factors and distribution of new CAC
Among all age, sex, and race groups, single-vessel CAC with LAD involvement was the most common phenotype. With increase in age, there was increased multivessel involvement of new CAC, which peaked in the age group of 65 to 74 years; however, single-vessel CAC with LAD involvement remained the most common presentation even in this age group (Table 3) . Males compared to females and Hispanic and Black compared to White and Chinese were associated with higher residual probability of multivessel new CAC involvement after multivariate adjustment ( Table 3) .
The residual probability of multivessel new CAC involvement was significantly higher in subjects with HTN, DM, and obesity after adjustment for the remaining risk variables. In current smokers and in subjects with LDL-C !160 mg/dL and total cholesterol-to-HDL-C ratio >3, there was no increased residual probability of multivessel new CAC involvement (Table 4 ).
Burden of new CAC
Among subjects with new CAC, 52% had CAC scores of 1 to 10, 44% had CAC scores of 11 to 100, and 4% had CAC scores >100. CAC burden was higher among subjects who developed CAC in visit 4 and 5 compared to those in visit 2 and 3 (Supplementary Table 1 ). The burden of new-onset CAC was significantly higher in subjects with multivessel CAC compared with those with 1 vessel involvement. Of those subjects with new CAC in a single vessel, 65% had CAC scores of 1 to 10, 34% had CAC scores of 11 to 100, and 1% had CAC scores >100. Of those subjects with multivessel involvement at the time of new CAC detection, 20% had CAC scores of 1 to 10, 68% had CAC scores of 11 to 100, and 12% had CAC scores >100 ( Table 5 ).
The median CAC score in subjects with single-vessel and multivessel involvement was 5.9 and 26.2, respectively. Among subjects with 1 vessel involvement, CAC was significantly higher in LAD and LM followed by RCA and then LCX ( Table 5 ). There was no difference in CAC burden by age, sex, and race groups. Subjects with new-onset advanced CAC (CAC >100) were equally distributed among all age, sex, and race groups (Supplementary Table 2 ). 
Factor
Baseline CAC ¼ 0 
5.
Discussion
Although CAC ¼ 0 is associated with excellent prognosis, presence of even mild CAC is associated with an increased risk of adverse events, and little is known about the transition from CAC ¼ 0 to initially detectable CAC >0. In MESA, we found that new CAC was most commonly found in a single vessel at first detection, with this pattern persisting among subjects of all age, sex, and race groups. Among the individual coronary arteries, the LAD was the most likely location for new CAC. Multivessel involvement of new CAC was more likely among males, Hispanics, Blacks, and in subjects with HTN, DM, and obesity. At the first detection of new CAC, the CAC burden was low, with <5% of subjects having a CAC score of >100. This is the first community-based study to describe the CAC distribution and CAC score burden at the initial detection of new CAC.
Prior studies on distribution of coronary atherosclerosis
The prevalent distribution of atherosclerosis in the coronary arteries has been described in prior cross-sectional studies. Pathological studies have shown that the prevalence and burden of atherosclerosis was higher in LAD, followed by RCA and then LCX. 18, 19 However, the differences have not been dramatic and some studies even observed roughly equal frequency of atherosclerosis in the LAD and the RCA and lower frequency in the LCX. 20, 21 Tuzcu et al, 22 using intravascular ultrasonography, showed that there was no statistically significant difference in distribution of lesions within different coronary arteries, although there was a trend toward higher prevalence in LAD and lower prevalence within LCX. It has been hypothesized that the preferential development of atherosclerosis in LAD can be due to the difference in the flow patterns in various anatomic locations of coronary arteries. 23 To our knowledge, there are no longitudinal studies describing the geographical incidence of atherosclerosis in the coronary arteries. Using CAC as a marker of atherosclerosis, we showed that incidence of new CAC is higher in LAD compared to RCA and LCX. However, we cannot rule out the possibility that calcium deposition occurs earlier in atherosclerotic lesions in LAD compared with lesions in other coronary arteries (RCA, LCX, and LM).
Comparison to prior CAC studies
In our analysis, we observed that traditional coronary heart disease risk factors including HTN, DM, smoking, high BMI, and high LDL levels are independently associated with development of new CAC. Similar results were seen in previous studies. 24e26 The percentage of subjects who developed new CAC (36%) was higher in our study compared to previous studies, 25, 26 which is likely due to the older patient population, higher risk factor burden, and longer follow-up of subjects in our study. Although a prior study by Min et al had the advantage of yearly CAC scanning, this study did not investigate the distribution of new CAC on first detection. 24 Detection of CAC is an excellent method of assessing atherosclerotic plaque presence, and it is important to note that the amount of calcium correlates with the overall magnitude of atherosclerotic plaque burden. 27 Previous crosssectional studies have suggested that quantity of CAC was significantly higher in LAD than in RCA and LCX. 28e30 However, to our knowledge, there are no longitudinal studies defining the origin and demographic distribution of new CAC in coronary arteries. Therefore, we have extended prior work by demonstrating that new CAC most commonly involves the LAD across all age, sex, and race groups.
The burden of new-onset CAC has been described in some of the studies mentioned previously. 25, 26, 31 In our study, 52% had a CAC score of 1 to 10, 44% had a CAC score of 11 to 100, and 4% had a CAC score of >100. Our study has a higher burden of new-onset CAC compared to the study by Gopal et al 31 (approximately 69% had CAC score of 1e9, 26% had CAC score of 10e50, and 5% had CAC score >50) and the burden is even less in the study by Koulaouzidis et al 26 (approximately 84% had CAC score of 1e9, 14% had CAC score of 10e50, and 2% had CAC score >50). Our study has an older patient population and higher traditional risk factor burden compared to prior studies, perhaps also explaining our observed burden of newonset CAC. In addition, lack of annual scanning resulting in increased lag period between the scans can be a contributing factor for the higher CAC burden at first detection in our study.
Cross-sectional burden of CAC among different age, sex, and race groups has been described in previous studies. 32e35 However, no studies have investigated the demographic variation of newly detected CAC. A striking finding from our study is that there is no difference in the burden of new CAC by age, sex, and race group.
Clinical implications
To our knowledge, there are no formal guidelines on repeat CAC testing for routine quantification of CAC progression 36 ; however, prior data suggest that a repeat scan in 4 to 5 years appears reasonable in individuals with a baseline score of CAC ¼ 0. 25, 26 We have shown that at the first detection of CAC >0, the burden is usually low (<100). This suggests that people rarely convert from CAC ¼ 0 to high CAC scores, which is important because high scores are associated with increased event rates. 37 Therefore, repeat scans to identity subjects with CAC >0 may allow detection while scores are still low and with adequate time to initiate aggressive preventive therapies. Whether this strategy can reduce cardiac events warrants further study. Our data also have implications for readers of cardiac CT scans, allowing readers to be familiar with the most common patterns of new-onset CAC.
Limitations
The principal limitation of this study is that annual CAC scanning was not performed. The timing of CAC scans was prespecified per the MESA protocol, which did not call for every participant to have scans at each follow-up visit. Therefore, it is impossible to know when exactly new CAC was developed, and our data should be considered time to first CAC detection rather than strict time to CAC incidence. However, the patterns and implications we have described should still hold, as lack of annual scanning would result in overestimation of the incidence of multivessel CAC and of CAC score burden at the first CAC detection.
In addition, we did not model change in risk factor or change in medication use over the course of the study. It is possible that changing behaviors or therapies may have had an effect on new-onset CAC. As the Agatston method was used to quantify CAC in our study, there is a possibility that certain lesions, especially those with low-density calcium and small areas of calcium (<1 mm 2 ) can be missed, which could influence our data. In our study, we do not have data regarding CAC distribution in different segments within individual coronary arteries. CAC analysis between coronary artery segments of similar length can provide a better picture of the segments with high chances of developing new CAC. Finally, although we demonstrated the coronary distribution and burden of new CAC, we did not study their prognostic implications. Studies on the prognostic significance of coronary distribution in MESA are forthcoming. 38 
Conclusion
Distinguished from referenced work by Min et al 25 and Kronmal et al, 24 this is the first study to describe the distribution of new CAC at its first detection. New-onset CAC most commonly affects 1 vessel and occurs in the LAD. The probability of multivessel involvement of new CAC is higher in certain high-risk groups. Of importance, CAC scores are usually low at onset of new CAC suggesting adequate time to increase aggressiveness of preventive therapies. 
